TransMedics Group (TMDX) Earnings Analysis
TransMedics Group (TMDX) next reports earnings on 2026-07-30, consensus EPS 0.5 USD. Last quarter (2025-10-29) it beat with EPS 0.66 USD vs 0.37 USD est (+78.4%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E 14.16.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TMDX next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 0.5 USD |
| Revenue estimate | 0.18B |
TMDX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-10-29 | 0.66 USD | 0.37 USD | +78.4% | Beat |
| 2025-02-27 | 0.19 USD | 0.22 USD | -13.6% | Miss |
| 2024-10-28 | 0.12 USD | 0.29 USD | -58.6% | Miss |
| 2024-07-31 | 0.35 USD | 0.21 USD | +66.7% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
TMDX valuation and analyst view
| Trailing P/E | 14.16 |
|---|---|
| Trailing EPS | 5 USD |
| Price / book | 4.96 |
| Dividend yield | 0.00% |
| Market cap | 2.46B |
| Analyst consensus | Buy (9 buy / 3 hold / 0 sell) |
| Avg price target | 107 USD |
Related research pages
Frequently asked questions
When is TransMedics Group (TMDX)'s next earnings date?
TransMedics Group is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.5 USD and revenue estimate of 0.18B.
Did TMDX beat earnings last quarter?
In its 2025-10-29 report, TMDX posted EPS of 0.66 USD versus a 0.37 USD estimate — a beat of 78.4%.
What is TMDX's earnings track record?
Over the last 4 reported quarters with consensus data, TMDX beat estimates 2 times (50%).
What is TMDX's current P/E ratio and EPS?
TMDX trades at a trailing P/E of 14.16 on trailing EPS of 5.000086231449223 USD.
What do analysts rate TMDX?
Analyst consensus is "Buy" across 12 ratings (0 strong buy, 9 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 107 USD.